COMMERCIAL STRATEGY
- Brand Relaunch of an over $150M revenue Enzyme Replacement Therapy for a rare genetically inherited Lysosomal Storage Disorder - Strategic Marketing of Orphan Drug portfolio in disease areas of Generalized Lipodystrophy and Homozygous Familial Hypercholesterolemia at Novelion
-Evaluated Product Launch strategy in the $60 billion Clinical Laboratory market for a Biotech start-up’s first diagnostic technology requirements at Quanterix - Strategic projects such as Design Thinking based Innovation Adoption and Global Market Research for Brand Effectiveness to support business continuity during Organizational Reform at Shire
-Developed Targeting/Call Strategy,Goal Setting and Incentive Compensation Plans for Rare Diseases US Sales Force which contributed to an annual sales growth of 46% resulting in combined product portfolio sales of ~$2.4 billion at Shire - Sold handicraft art products to retail stores for 3 years to develop a new market segment